Literature DB >> 45521

Emergence of antibiotic resistance in hospitals, 1935-1975.

M Finland1.   

Abstract

A limited review of the changes in susceptibility of common bacterial pathogens to available antibacterial agents is presented. Significant developments in recent years include the following: (1) the emergence of Streptococcus pneumoniae with decreased resistance to penicillin and of some strains resistant to several antibiotics; (2) a decline in prevalence of multi-drug-resistant Staphylococcus aureus after 1960 following their increasing prevalence in the preceding years (these changes were methicillin-resistant (and multi-drug-resistant) S. aureus and the marked differences in their prevalence in different areas (these changes also were related to appearance of new phages in those organisms); (4) an increasing resistance to multiple drugs among enterococci but not among viridans streptococci or among nonenterococcal group D streptococci; (5) the emergence of beta-lactamase-producing Neisseria gonorrhoeae; (6) the emergence and spread of sulfonamide-resistant Neisseria meningitidis; (7) the occurrence of beta-lactamase-producing strains of Haemophilus influenzae and occasional strains resistant to chloramphenicol; (8) the focal occurrence of chloramphenicol-resistant Salmonella typhi in Vietnam and in epidemic form in Mexico; (9) the demonstration of marked differences in prevalence of resistance to multiple drugs in common pathogens to the most widely used antibiotics in different geographic areas. The dominant factor in the emergence and spread of antibiotic-resistant bacterial pathogens, whether in hospital wards or in the community, is clearly the intensive use of the antibiotic agents to which resistance emerges and then spreads.

Entities:  

Mesh:

Year:  1979        PMID: 45521     DOI: 10.1093/clinids/1.1.4

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  25 in total

Review 1.  Origins and evolution of antibiotic resistance.

Authors:  Julian Davies; Dorothy Davies
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

Review 2.  Discovery and development of new antimicrobial agents.

Authors:  T D Gootz
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 3.  Overview on the role of heavy metals tolerance on developing antibiotic resistance in both Gram-negative and Gram-positive bacteria.

Authors:  Raju Biswas; Urmi Halder; Ashutosh Kabiraj; Amit Mondal; Rajib Bandopadhyay
Journal:  Arch Microbiol       Date:  2021-04-02       Impact factor: 2.552

4.  Broad geographical distribution of homologous erythromycin, kanamycin, and streptomycin resistance determinants among group D streptococci of human and animal origin.

Authors:  D J LeBlanc; J M Inamine; L N Lee
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

5.  Human influences on evolution, and the ecological and societal consequences.

Authors:  Andrew P Hendry; Kiyoko M Gotanda; Erik I Svensson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-01-19       Impact factor: 6.237

Review 6.  Integrated Multilevel Surveillance of the World's Infecting Microbes and Their Resistance to Antimicrobial Agents.

Authors:  Thomas F O'Brien; John Stelling
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

7.  What do beta-lactamases mean for clinical efficacy?

Authors:  H C Neu
Journal:  Infection       Date:  1983       Impact factor: 3.553

8.  Antimicrobial resistance among Salmonella serovars isolated from different sources in Brazil during 1978-1983.

Authors:  L C Campos; E Hofer
Journal:  Antonie Van Leeuwenhoek       Date:  1989-04       Impact factor: 2.271

9.  Evidence for a chromosome-borne resistance transposon (Tn916) in Streptococcus faecalis that is capable of "conjugal" transfer in the absence of a conjugative plasmid.

Authors:  A E Franke; D B Clewell
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

10.  Curbing the menace of antimicrobial resistance in developing countries.

Authors:  Chidi Victor Nweneka; Ndey Tapha-Sosseh; Anibal Sosa
Journal:  Harm Reduct J       Date:  2009-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.